Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

175
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
175
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

284
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
284
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

152
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
152
Esophagus01:24

Esophagus

1.3K
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
1.3K
Upper GI Series: Barium Swallow01:24

Upper GI Series: Barium Swallow

804
The Barium Swallow Study, or a Barium Esophagogram, is a diagnostic imaging method used to visualize the upper gastrointestinal (GI) tract, including the esophagus, stomach, and small intestine. It employs barium sulfate, a radiopaque contrast material, to provide clear images of the upper digestive system, helping to identify abnormalities, diseases, or structural issues.
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
804
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

124
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
124

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

H-NS is a bacterial transposon capture protein.

Nature communications·2024
Same author

Effects of Lower Limb Proprioceptive Training on Balance and Trunk Control Among the Adult Stroke Population.

Cureus·2024
Same author

Prospective evaluation of blood pressure, heart rate, and side effects in hypertensive patients using low-dose oral minoxidil for hair loss.

Journal of the American Academy of Dermatology·2024
Same author

Evaluation of response to neoadjuvant chemotherapy in technically unresectable moderately advanced oral cavity cancers.

Journal of cancer research and therapeutics·2024
Same author

Assessment of quality of life in head and neck cancer patients visiting the Palliative Care outpatient department in a tertiary care oncology centre in India.

Indian journal of cancer·2024
Same author

Therapeutic potential of transient receptor potential (TRP) channels in psychiatric disorders.

Journal of neural transmission (Vienna, Austria : 1996)·2024

Video Experimental Relacionado

Updated: Sep 1, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.1K

El esófago de Barrett: una revisión

Prateek Sharma1

  • 1University of Kansas School of Medicine, VA Medical Center, Kansas City, Kansas.

JAMA
|August 16, 2022
PubMed
Resumen

El esófago de Barrett, una afección que afecta al 5% en los Estados Unidos, aumenta el riesgo de adenocarcinoma esofágico. El tratamiento incluye la supresión del ácido y la vigilancia, con terapia endoscópica para la displasia o el cáncer temprano.

Área de la Ciencia:

  • Gastroenterología y Oncología
  • Enfermedades del esófago
  • Metaplasia y progresión del cáncer

Sus antecedentes:

  • El esófago de Barrett implica el reemplazo de células escamosas esofágicas por metaplasia columnar.
  • Afecta al 5% en los Estados Unidos y al 1% a nivel mundial, con un riesgo de adenocarcinoma esofágico del 3-5% durante toda la vida.
  • Los factores de riesgo incluyen la edad avanzada, el sexo masculino, el tabaquismo y la enfermedad por reflujo gastroesofágico (ERGE).

Objetivo del estudio:

  • Para resumir la epidemiología, los factores de riesgo y el tratamiento del esófago de Barrett.
  • Para resaltar la progresión de la metaplasia al adenocarcinoma.
  • Discutir las estrategias actuales de tratamiento y vigilancia.

Principales métodos:

  • Revisión de la literatura de datos epidemiológicos y observaciones clínicas.

Más Videos Relacionados

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.1K
Surgical Models of Gastroesophageal Reflux with Mice
05:19

Surgical Models of Gastroesophageal Reflux with Mice

Published on: August 25, 2015

10.2K

Videos de Experimentos Relacionados

Last Updated: Sep 1, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.1K
Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.1K
Surgical Models of Gastroesophageal Reflux with Mice
05:19

Surgical Models of Gastroesophageal Reflux with Mice

Published on: August 25, 2015

10.2K
  • Análisis de los factores de riesgo y las tasas de prevalencia.
  • Resumen de las directrices actuales de manejo y resultados terapéuticos.

    • Principales resultados:

    • La prevalencia del esófago de Barrett varía, con tasas más altas en hombres mayores y fumadores.
    • La tasa anual de progresión al adenocarcinoma esofágico es del 0,2% al 0,5%.
    • La terapia endoscópica es eficaz para la displasia/ cáncer precoz en el 80-90% de los pacientes.

    Conclusiones:

    • El esófago de Barrett requiere vigilancia debido al riesgo de adenocarcinoma.
    • Los inhibidores de la bomba de protones controlan la ERGE, pero su función quimiopreventiva es incierta.
    • Se recomienda la vigilancia endoscópica, aunque se necesitan ensayos aleatorios.